Eli Lilly and Company
Amino pyrimidine compounds useful as SSAO inhibitors
Last updated:
Abstract:
The present invention provides compounds of the formula below ##STR00001## pharmaceutically acceptable salts of the compounds, methods of treating patients for liver disease, and processes for preparing the compounds.
Status:
Grant
Type:
Utility
Filling date:
18 Mar 2019
Issue date:
12 Nov 2019